Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
Clinical trial NCT05429684 · UNKNOWN
Trial details
- NCT number
- NCT05429684
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-02-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.